|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.65 HKD | -0.50% |
|
-5.04% | -3.26% |
Business description: RemeGen Co., Ltd.
Number of employees: 3,048
Sales by Activity: RemeGen Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Biopharmaceutical Research,Service,Production and Sales | 142.39Cr | 77Cr | 108.3Cr | 171.69Cr | 325.11Cr |
Geographical breakdown of sales: RemeGen Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Mainland China | 13Cr | 72Cr | 105.43Cr | 170.42Cr | 227.64Cr |
USA | 129.26Cr | 4.44Cr | 2.87Cr | 1.27Cr | 97Cr |
Executive Committee: RemeGen Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Min Fang
CEO | Chief Executive Officer | 64 | 04/07/2008 |
Shao Jing Tong
DFI | Director of Finance/CFO | 55 | 28/09/2023 |
Qing Kai Wen
SEC | Corporate Secretary | 60 | 11/05/2020 |
Wei Liang
IRC | Investor Relations Contact | 43 | - |
Composition of the Board of Directors: RemeGen Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Jian Min Fang
BRD | Director/Board Member | 64 | 04/07/2008 |
Jian Lin
BRD | Director/Board Member | 71 | 04/07/2008 |
Liqiang Wang
BRD | Director/Board Member | 56 | 11/05/2020 |
Xiaodi Su
BRD | Director/Board Member | 40 | 11/05/2020 |
Xian Jing Hao
BRD | Director/Board Member | 61 | 11/05/2020 |
Qing Kai Wen
BRD | Director/Board Member | 60 | 02/04/2025 |
Wei Dong Wang
CHM | Chairman | 67 | 21/06/2019 |
Ren Guangke
CHM | Chairman | 53 | - |
Li Yupeng
BRD | Director/Board Member | 43 | 11/05/2020 |
Li Zhuan Glin
BRD | Director/Board Member | 52 | 11/05/2020 |
Holdings: RemeGen Co., Ltd.
| Name | Stocks | % | Valuation |
|---|---|---|---|
VOR BIOPHARMA INC. -.--% | 0 | -.--% | - $ |
Company details: RemeGen Co., Ltd.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | -5.04% | +45.26% | +115.63% | 728.47Cr | |
| +1.65% | +6.42% | +53.16% | +109.62% | 5.48TCr | |
| +0.03% | -1.80% | +49.57% | +43.94% | 4.33TCr | |
| +2.98% | -0.36% | -15.35% | -18.69% | 2.18TCr | |
| +5.15% | -7.06% | -0.47% | +400.08% | 1.99TCr | |
| +0.81% | -8.38% | +12.77% | -33.24% | 1.57TCr | |
| +0.53% | +2.08% | +8.89% | -40.13% | 1.53TCr | |
| +1.68% | +2.03% | +29.27% | +180.54% | 1.32TCr | |
| -5.27% | +3.89% | +90.88% | +208.02% | 1.16TCr | |
| -1.74% | -1.05% | +12.88% | - | 1.19TCr | |
| Average | +0.57% | -0.98% | +28.68% | +107.31% | 2.15TCr | |
| Weighted average by Cap. | +1.05% | +0.97% | +32.47% | +98.49% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 9995 Stock
- Company RemeGen Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
